Logo image
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors
Journal article   Open access   Peer reviewed

Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors

Molly A Vickers, Alan Sariol, Judith Leon, Alexandra Ehlers, Aaron V Locher, Kerry A Dubay, Laura Collins, Dena Voss, Abby E Odle, Myrl Holida, …
Transfusion (Philadelphia, Pa.), Vol.61(7), pp.2099-2106
04/08/2021
DOI: 10.1111/trf.16401
PMID: 33829513
url
https://doi.org/10.1111/trf.16401View
Published (Version of record) Open Access

Abstract

With the recent approval of COVID-19 vaccines, recovered COVID-19 subjects who are vaccinated may be ideal candidates to donate COVID-19 convalescent plasma (CCP). Eleven recovered COVID-19 patients were screened to donate CCP. All had molecularly confirmed COVID-19, and all but one were antibody positive by chemiluminescence immunoassay (DiaSorin) prior to vaccination. All were tested again for antibodies 11-21 days after they were vaccinated (Pfizer/Moderna). All showed dramatic increases (~50-fold) in spike-specific antibody levels and had at least a 20-fold increase in the IC50 neutralizing antibody titer based on plaque reduction neutralization testing (PRNT). The spike-specific antibody levels following vaccination were significantly higher than those seen in any non-vaccinated COVID-19 subjects tested to date at our facility. Spike-specific and neutralizing antibodies demonstrated dramatic increases following a single vaccination after COVID-19 infection, which significantly exceeded values seen with COVID-19 infection alone. Recovered COVID-19 subjects who are vaccinated may make ideal candidates for CCP donation.
immunology (other than RBC serology) transfusion Practices (Adult)

Details

Metrics

Logo image